Newstral
Article
South China Morning Post on 2020-02-03 10:04
China starts clinical trials for new antiviral drug to treat coronavirus
Related news
- China begins clinical trials for new ARV to treat coronavirusvanguardngr.com
- SChinese trials for Gilead’s antiviral drug to treat coronavirus still far from reaching patient recruitment goalsscmp.com
- Antiviral drug remdesivir fails first randomised clinical trial, according to WHO documentNew Statesman
- WChina approves new drug to treat Alzheimer’s; clinical trials planned for 2020 in USwraltechwire.com
- Antiviral drug being tested to treat coronavirusCNN
- Covaxin starts clinical trials, 375 people enrolledThe Times of India
- Covid vaccine: Bharat Biotech starts clinical trialsThe Times of India
- BThe Pandemic Is Disrupting Clinical Drug Trialsbarrons.com
- FAxovant Alzheimer’s drug fails in clinical trialsft.com
- DCGI nod for Glenmark Pharma clinical trials on Favipiravir antiviral tablets for COVID-19 patientsThe Hindu
- BCoronavirus Outbreak Could Disrupt Drug Companies’ Clinical Trialsbarrons.com
- TChina: Phase III clinical trials for anti-goiter drug begintumblerridgenews.com
- Ebola drug in clinical trial to treat coronavirusvanguardngr.com
- Iran starts clinical trial on effectiveness of coronavirus drugtehrantimes.com
- Can ancient mushrooms and Chinese herbs treat COVID? Clinical trials set to find outsacbee.com
- University of Hawaii opens first COVID-19 clinical trials to treat patientsstaradvertiser.com
- Japanese Flu Drug ‘Effective’ Against Coronavirus In Clinical Trials, Chinese Officials SayForbes
- Coronavirus: US starts distributing Gilead Sciences’ antiviral drug to states most in needSouth China Morning Post
- Gilead Stock Jumps 8% After Coronavirus Drug Remdesivir Shows ‘Rapid Recoveries’ In Clinical TrialsForbes
- If Bill Gates Turned to Philanthropy: Publicly Funded Clinical Drug Trialshuffingtonpost.com